Conformal Medical’s Post

As we hit the #RoadToEurope we’re showcasing the innovators from around the globe who are selected to present at #LSIEurope24. Today we’re showcasing 3 innovators in Ireland selected to present at LSI Europe ‘24 in Portugal: 1. Declan Soden — Mirai Medical → Its ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment. 2. Finbar (Barry) Dolan — VERSONO MEDICAL LTD → Developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI). 3. Stephen Cox — InVera Medical → Developing a catheter-based therapy for chronic venous disease. The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels. We look forward to seeing these innovators take the stage this September 16th - 20th in Portugal. Want to see what other innovators are presenting at LSI Europe ‘24? Head over to our website to see the first 100+ innovators selected to present.

As we hit the #RoadToEurope we’re showcasing global innovation from the innovators selected to present at #LSIEurope23. 🇮🇪 Today we’re showcasing 3 Innovators in Ireland selected to present at LSI Europe ‘23: 1. Mirai Medical — Declan Soden (Presenter) → Developing technology that greatly improves cancer outcomes and enhances patient experiences. Its ePORE therapy is a unique precision therapy platform that targets and destroys tumor tissue without harming surrounding healthy tissue. 2. Ostoform Ltd — Kevin Kelleher (Innovator Pavilion) → The company’s mission is to improve skin health and quality of life in people living with an ostomy. Its Ostoform device prevents and protects the seal adhesive from the output of the ileostomy leaking onto the patient's skin, keeping skin healthy and giving the patient confidence, while simultaneously directing output into the ostomy pouch. 3. Neuromod Devices — Ross O'Neill (Presenter) → Focused on utilizing bimodal neuromodulation to treat chronic neurological conditions. The lead application for the company's technology is the Lenire device for the treatment of tinnitus. It combines synchronized stimulation of the auditory nerve and nerves of the tongue to soothe and relieve tinnitus. Want to see what other innovators are also attending LSI Europe ‘23? Check out our website and event page using the link in the comments.

Do you know any of your friends or loved ones wearing a stoma due to cancers in the lower gastrointestinal track? Could it be avoided with a better option to allow patients to live a normal life for removing these cancers? The answer is yes as Dr Khor from Singapore General Hospital explains in the video attached. Please like the video on YouTube if you like this innovative treatment option! https://lnkd.in/gUG3kA-P

On October 27, 2023, a comprehensive NPCDCS - VIA (Visual Inspection with Acetic Acid) training was organized at SDH Dharampur for the medical officers of PHC/CHC/SDH. The distinguished trainers for this enlightening event were: 1. Dr. Rakesh Patel (Medical Superintendent) 2. Dr. Harish Jadav (Gynecologist) Key Topics Explored: 1. Introduction to Cervical Cancer 2. Gross Anatomy of the Cervix 3. Visual Inspection with Acetic Acid and Lugol 4. Clinical Demonstrations 5. Screening and Treatment Approaches This session proved to be an exceptional learning opportunity, combining both theoretical knowledge and valuable clinical experience through patient demonstrations. A remarkable initiative to enhance medical expertise and combat cervical cancer effectively. #MedicalTraining #CervicalCancerAwareness

Did you know? In the 80's, the #IASLC hosted the 2nd #WCLC in Denmark, 3rd in Japan, 4th in Canada & 5th in Switzerland, w/steady growth in registrants & submitted abstracts, highlighting advances in #lungcancer surgical techniques, staging system refinements, new studies & much more! #IASLC50

The power of Self Expending Valves

I presented the topic titled ‘CT Based On-Table Adaptive Radiotherapy’ at the UROK 2023 Congress.

The collaboration between Elekta and Business Sweden in South America demonstrates how Business Sweden can support growth in new markets and enable focus on your core business.

For a #Troponin test to be useful at #PointOfCare testing (#POCT) for the rule in/out of #myocardialinfarction, it must comply with the high-sensitivity definition (either being #hsTnI or #hsTnT) and it must be used in an accelerated #diagnostic #algorithm, for instance being tested at arrival (0 hour) plus a second sample at 1 hour or 2 hour depending on the protocol at the hospital. A POCT test unable to use accelerated 0/1h or 0/2h protocols wouldn't provide any time advantage vs. a #ClinicalLaboratory in the same institution which can use such accelerated diagnostic algorithms. Here a couple of publications proving that nowadays Point of Care high-sensitivity troponin is ready for those accelerated protocols: 1. QuidelOrtho's #TriageTrue validated for use with a 0/1h algorithm https://lnkd.in/ddMn8WFF 2. Siemens Healthineers's VTLi in a study using a 0/2h algorithm https://lnkd.in/dfNrpcDk hsTnI at POCT is ready for prime-time in those geographies with regulatory approvals, which is the biggest #marketaccess barrier for troponin tests. #laboratorymedicine #biomarkers #IVD #cardiology #emergencymedicine

Book your time slot during #FRPT2023 to talk with THERYQ team about #FlashRT #Flashradiotherapy #cancerresearch #innovation. Happy to get your insights!